Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
about
How I treat acquired aplastic anemiaMutations in the SBDS gene in acquired aplastic anemiaCurrent concepts in the pathophysiology and treatment of aplastic anemiaClonal hematopoiesis in acquired aplastic anemiaEltrombopag in aplastic anemiaClonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesParoxysmal nocturnal hemoglobinuria in pediatric patients.High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upTranslocation (8;21) acute myeloid leukemia presenting as severe aplastic anemia.A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition.Clinical and cytogenetic analysis of human anemias from Jammu region of Jammu and Kashmir stateShort telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia.Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.Bone marrow failure and the telomeropathies.Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adultsAplastica anemia and viral hepatitisEltrombopag Added to Standard Immunosuppression for Aplastic Anemia.T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapyGranulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptorSNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors.Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features.CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins.Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles.Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.Gene expression profiling in the myelodysplastic syndromes.Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemiaTelomere maintenance and human bone marrow failureFavorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designationAn update on the management of severe idiopathic aplastic anaemia in children.Comment to "Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation" Haematologica. 2012;97(12):1845-9.Cytogenetic profile of aplastic anaemia in Indian children.Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention.
P2860
Q24617687-B15175EF-A078-4E1B-A964-1E3D05B551CBQ24682080-27722491-ED5B-4B46-95DA-F6C956C1C3E3Q24685812-B5FDA851-580F-4341-BDB6-BBFFEDD15BCAQ28079733-954C6DEC-C17B-4014-A71C-28B39469BD79Q28085299-2410EFF2-452D-44BE-AE80-13A974A0D437Q28392451-E0DF8C4F-7A5E-43E0-B890-6A43B2FAAAC6Q33398617-303CD18D-5E8E-4F0C-8A66-76ACBAB13B5FQ33747331-612DD9C6-1985-478E-A868-08E5BD497F5FQ33846627-65A4074B-1DB6-4926-B288-FE00CA8E4210Q34065882-2157F0E4-B39E-4350-8DE5-CA89A2E45740Q34118831-82EEC08B-0296-40F8-8A54-B7ED611DE83BQ34212939-BC9182AB-DCCC-47AC-A381-DD082749DA25Q34392449-059BA5E5-C039-4CD2-88E4-372F091BD764Q34428974-FF19C1E8-02CD-4660-A69D-75D259251784Q34431411-F4D7CBE7-6DB5-4341-9826-F3DA00010D5AQ34501072-AE20F6C1-B909-4125-8F74-15ADAD25FB4EQ34549277-23B6FA67-FF3D-47ED-9F66-B365752F0519Q34555435-42EADF6C-8CF3-46E6-8437-EE12B14EC1CCQ34707452-01494BB2-6EA3-4A38-9F59-E4C65A4769C8Q35080710-5536DD5E-55FD-4548-9816-EDF7B1C68EBBQ35083258-1BCD6F81-E18B-4B27-A508-1A653DA15C4FQ35252614-1B72E522-0FDB-43F4-A17C-43F6DEFE0481Q35605853-A3EFB359-B7B6-48E1-AE17-7695873DBC8DQ35661305-9DF8186B-729C-47C1-B30C-D9616A906DC7Q35746083-34586633-933C-418E-BC3E-B2A1C8E6B8DFQ35750889-6F534221-5F46-432C-AC01-B6BF5930AF29Q35847917-5A7F759B-3E75-464B-BE28-5725E4C1C411Q35848521-51DA2A6A-ACB2-44E9-A8A6-BD7E145B8FC4Q35989473-9780FC9B-EB9E-4721-8BB7-E4A5F48D9607Q36221521-75E8A1B8-2105-402F-8FF9-9A6CEF729BAAQ36512538-9DEFD831-B9CC-4BA4-A1DD-69C71EBD2B93Q36535499-24181B6F-8473-4753-A887-36807F6C7D7CQ36591289-93BBEC08-CC5B-4BCB-BC1D-8DB8C8993217Q36662033-F304D53A-9B42-491B-985C-155856261D76Q36703904-F9C7108D-BC77-481A-9606-44FC3FE9F046Q36862562-98360C39-A210-4AE0-8E99-C8EBF76015A3Q36994933-AC6442A0-17B8-4EA7-BBB9-9279F00F9859Q37005060-D86B5C75-E20F-4978-8A24-7AA5C16F7651Q37040876-4EC32EA2-C9C1-415A-8FDB-46005091270EQ37229440-950A66D8-82F9-416E-BA2B-64F673AD5F70
P2860
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
@en
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
@nl
type
label
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
@en
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
@nl
prefLabel
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
@en
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
@nl
P2093
P356
P1433
P1476
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
@en
P2093
Antonio Risitano
Elaine M Sloand
Jaroslaw P Maciejewski
Neal S Young
Olga Nunez
P304
P356
10.1182/BLOOD.V99.9.3129
P407
P577
2002-05-01T00:00:00Z